米非司酮联合小金胶囊治疗子宫内膜异位症的临床研究  

Clinical Research on Effects of Mifepristone Combined with Xiaojin Capsule in the Treatment of Endometriosis

作　　者：张媛媛[1] 李丽[1] 薛娟[1] 白彩云[1] 冯红礼 Zhang Yuanyuan Li Li Xue Juan Bai Caiyun Feng Hongli(Department of Obstetrics and Gynecology, Affiliated Hospital of Yan ＇an University, Yah＇an 716000, China Xi＇an Polytech University Hsopital, Xi＇an 710048, China)

机构地区：[1]延安大学附属医院妇产科,延安716000 [2]西安工程大学医院,西安710048

出　　处：《世界中医药》2017年第9期2047-2049,共3页World Chinese Medicine

基　　金：2016年国家中医药管理局中药标准行动计划--小金胶囊标准化建设

摘　　要：目的:观察米非司酮联合小金胶囊治疗子宫内膜异位症的临床疗效。方法:将本院120例符合子宫内膜异位症诊断标准的患者随机分为2组。对照组60例.给予米非司酮口服治疗。观察组60例,给予米非司酮联合小金胶囊口服。2组患者均连续治疗6个月后,观察2组治疗后的有效率、血清CA125、性激素水平、复发率及不良反应发生率等指标。结果:观察组临床总有效率均高于对照组(P<0.05),血清CA125、复发率低于对照组(P<0.05);2组性激素水平无明显差异(P>0.05)。结论:米非司酮联合小金胶囊对子宫内膜异位症有一定的疗效,值得临床推广。Objective： To observe the clinical effect of mifepristone combined with Xiaojin Capsule in the treatment of endometriosis. Methods： A total of 120 patients diagnosed as uterine fibroids were randomized divided into 2 groups. The control group（ 60patients） were treated with Mifepristone,and the treatment group（ 60 patients） were added Xiaojin capsule. The effective rate,the levels of CA125,the levels of sex hormone,recurrence rate and adverse reaction of two groups after continuous 6 months’ treatment were observed. Results： The total effective rate of treatment group was significantly higher than that of control group（ P 〈 0 05）,and the levels of CA125 and recurrence rate were lower than that of control group. There was no significant difference in the levels of sex hormone（ P 〉 0. 05）. There were no significant difference in sex hormone levels of two groups（ P 〉 0. 05）. Conclusion：Mifepristone combined with Xiaojin capsule is effective for patients with endometriosis,which is worthy of clinical promotion.

关 键 词：子宫内膜异位症 小金胶囊 米非司酮 

分 类 号：R242[医药卫生—中医临床基础] R271.1[医药卫生—中医学]